Sector
PharmaceuticalsOpen
₹50Prev. Close
₹50Turnover(Lac.)
₹0.15Day's High
₹50.8Day's Low
₹49.152 Week's High
₹58.452 Week's Low
₹33.2Book Value
₹0.07Face Value
₹1Mkt Cap (₹ Cr.)
232.31P/E
0EPS
0Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|
Equity Capital | 4.73 | 4.73 | 4.73 | 4.64 |
Preference Capital | 0 | 0 | 0 | 0.1 |
Reserves | 0.73 | 10.16 | 13.71 | 8.64 |
Net Worth | 5.46 | 14.89 | 18.44 | 13.38 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Revenue | 132.71 | 106.28 | 1.46 | 0.19 |
yoy growth (%) | 24.86 | 7,179.88 | 660 | -89 |
Raw materials | -96.85 | -80.24 | -0.35 | -0.08 |
As % of sales | 72.97 | 75.5 | 24.24 | 42.54 |
Employee costs | -14.09 | -10.8 | -0.83 | -2.13 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Profit before tax | 5.53 | 1.22 | -1 | -4.04 |
Depreciation | -1.91 | -1.66 | -0.34 | -0.29 |
Tax paid | -0.43 | 0.15 | 0.07 | 0 |
Working capital | 5.9 | 31.91 | -0.32 | 1.93 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 24.86 | 7,179.88 | 660 | -89 |
Op profit growth | 88.23 | -553.78 | -70.97 | 76.22 |
EBIT growth | 137.67 | -609.74 | -78.87 | 110.41 |
Net profit growth | 269.61 | -248.57 | -77.06 | 138.02 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,896.45 | 163.49 | 4,55,021.88 | 237.82 | 0.71 | 4,409.74 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 5,923.75 | 94.67 | 1,57,256.95 | 430 | 0.51 | 2,063 | 507.93 |
Cipla Ltd CIPLA | 1,522.95 | 30.97 | 1,22,988.41 | 1,055.94 | 0.85 | 3,752.25 | 346.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,392.8 | 76.4 | 1,14,822.61 | 469 | 0.83 | 2,394 | 201.77 |
Dr Reddys Laboratories Ltd DRREDDY | 6,696.1 | 27.12 | 1,11,742.47 | 1,417.2 | 0.6 | 5,823.9 | 1,458.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Sameer Goel
Independent Director
Jagdeep Dhavvan
Independent Director
Richa Gupta
Director
Vipul Goel
Company Sec. & Compli. Officer
Lakshay Prakash
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Kimia Biosciences Ltd
Summary
Kimia Bio-sciences Limited (Formerly known Laurel Organics Limited) was incorporated in September, 1993 led by the Promoters, A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal. The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana. The Company is engaged into the business of Pharamaceutical products.The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr. It came out with a public issue in Feb.95 to part-finance the project. Commercial production commenced in May 95. During the 1998-99, the company has become a sick industrial units.The Honble BIFR vide order dated 27th December, 2005 had deregistered the Company as Sick Industrial Undertaking on the ground that 100% of the capacity was utilized for manufacture of the intermediate products for M/s Ranbaxy Laboratoty Limfted (RLL) and , thereby, turning-out to be an ancillary industrial Undertaking. .The Honble AAIFR disposed the appeal of M/s Ranbaxy Lab. Ltd vide its Order dated 30.08.2006, directing them to file an application before the Hoble BIFR only to redress grievances. Therefore, M/s Ranbaxy Lab. Ltd had filed an application-dated 31.10.06 before the Honble BIFR, requesting them to consider issuance of appropriate corrective orders. The Board has re-confirmed its earlier order. Therefore, despite negative net worth, the Company is out of BIFR purview.During the year 2017-18, the Scheme of Arrangement for Am
Read More
The Kimia Biosciences Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹49.1 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Kimia Biosciences Ltd is ₹232.31 Cr. as of 21 Oct ‘24
The PE and PB ratios of Kimia Biosciences Ltd is 0 and 714.10 as of 21 Oct ‘24
The 52-week high/low is the highest and lowest price at which a Kimia Biosciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Kimia Biosciences Ltd is ₹33.2 and ₹58.4 as of 21 Oct ‘24
Kimia Biosciences Ltd's CAGR for 5 Years at 13.20%, 3 Years at 5.83%, 1 Year at 35.49%, 6 Month at -9.28%, 3 Month at -1.99% and 1 Month at -3.64%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice